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Abstract
Background: Live attenuated Leishmania donovani parasites as LdCen−/− were shown to confer protective
immunity against Leishmania infection in mice, hamsters, and dogs. Strong immunogenicity in dogs vaccinated
with LdCen−/− has been previously reported, including increased antibody response favoring Th1 response
lymphoproliferative responses, CD4+ and CD8+ T-cells activation, increased levels of Th1 and reduction of Th2
cytokines, in addition to a significant reduction in parasite burden after 18 and 24 months post virulent parasite
challenge.
Methods: Aimed at validating a new method using in vitro co-culture systems with macrophages and purified CD4+
or CD8+ or CD4+:CD8+ T-cells of immunized dogs with both LdCen−/− and Leishmune® to assess microbicide capacity
of macrophages and the immune response profile as the production of IFN-γ, TNF-α, IL-12, IL-4 and IL-10 cytokines.
Results and discussion: Our data showed co-cultures of macrophages and purified T-cells from dogs immunized with
LdCen−/− and challenged with L. infantum were able to identify high microbicidal activity, especially in the co-culture
using CD4+ T-cells, as compared to the Leishmune® group. Similarly, co-cultures with CD8+ T-cells or CD4+:CD8+ T-cells in
both experimental groups were able to detect a reduction in the parasite burden in L. infantum infected macrophages.
Moreover, co-cultures using CD4+ or CD8+ or CD4+:CD8+ T-cells from immunized dogs with both LdCen−/− and
Leishmune® were able to identify higher levels of IFN-γ and IL-12 cytokines, reduced levels of IL-4 and IL-10, and a higher
IFN-γ/IL-10 ratio. While the highest IFN-γ levels and IFN-γ/IL-10 ratio were the hallmarks of LdCen−/− group in the co-
culture using CD4+ T-cells, resulting in strong reduction of parasitism, the Leishmune® immunization presented a
differential production of TNF-α in the co-culture using CD4+:CD8+ T-cells.
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Conclusion: The distinct conditions of co-culture systems were validated and able to detect the induction of immune
protection. The method described in this study applied a new, more accurate approach and was able to yield laboratory
parameters useful to test and monitor the immunogenicity and efficacy of Leishmania vaccines in dogs.
Keywords: Vaccine, In vitro co-culture, CD4+ and CD8+ T-cells, Canine visceral leishmaniasis LdCen−/−, Leishmune®
Background
Leishmaniasis is a protozoonosis that is endemic in several
countries around the world, with more than 350 million
cases being visceral leishmaniasis [1]. The impact of con-
trolling the infected dog population to reduce human vis-
ceral leishmaniasis prevalence in these endemic areas has
been debated [2–4]. Therefore, the development of a canine
visceral leishmaniasis (CVL) vaccine is highly desirable and
would represent the most practical and efficient control
tool [5].
A key goal in the control of CVL has been the devel-
opment of vaccines with high protective capability to
interrupt the parasite transmission [6]. Assessments of
vaccine safety and anti-CVL efficacy generally require a
long follow-up, extending into years of study [7–9].
Thus, researchers need to develop methodological strat-
egies that enable a more rapid and accurate evaluation
of the dog’s immune system. Such tests could be in-
cluded in clinical trials of vaccines against CVL, so that
the time needed for the experiments could be reduced.
This would likely reduce the costs of experimentation
using the dog model and provide a more rational way of
selecting candidate vaccines against CVL.
Among the live-attenuated parasites used as vaccines, the
centrin deletion in L. donovani (LdCen−/−) has been shown
to specifically affect the cytokinesis and lead to multinucle-
ated cells and eventual cell death of amastigote forms while
the growth of promastigote forms is unaffected. Previous
studies evaluated the protective immunity of LdCen−/− and
demonstrated the safety, immunogenicity, and protection
against infection with wild type L. donovani in mice and
hamster models [10]. Recently, we have demonstrated that
immunization with LdCen−/− results in an increase in
immunoglobulin isotypes, higher lymphoproliferative
response, higher frequencies of activated CD4+ and CD8+
T-cells, IFN-γ production by CD8+ T-cells, increased secre-
tion of TNF-α and IL-12, and decreased secretion of IL-4,
as well as a significant reduction in parasite burden 18 and
24 months after experimental challenge in dogs [11].
Recently, an in vitro co-culture system using macro-
phages and purified T-cells was standardized to analyze
the adaptive immune response in dogs immunized
against CVL [12]. In this study, we applied the same
method using LdCen−/− and Leishmune® vaccines, which
have been reported to induce a strong immune response
against canine visceral leishmaniasis. The microbicidal
capability of macrophages co-cultured with CD4+ or
CD8+ T-cells or CD4+:CD8+ T-cells simultaneously was
assessed after in vitro infection with L. infantum and the
cytokine levels were analyzed from dogs after 24 months
of the experimental challenge with L. infantum. The re-
sults suggest that this in vitro co-culture system allows




The wild type strain of L. infantum (MHOM/BR/1970/
BH46) was used for the in vitro co-culture system. The
parasites were grown in NNN/LIT (Sigma Chemical Co.,
USA) culture medium supplemented with inactivated
20 % fetal bovine serum (FBS) (Cultilab, Brazil), plus
penicillin (200 U/ml) and streptomycin (100 μg/ml), at
pH 7.4 and incubation temperature of 23 °C. Parasites
used for in vitro tests were removed from the culture at
the stationary phase (seventh day of culture) during the
seventh passage. Parasites were counted in a Neubauer
chamber, from which more than 90 % viability was ob-
tained and later used for in vitro infection.
Animals and vaccination protocol
Eighteen healthy beagle dogs with 8 months of age were
divided into three groups (three males and three females
per group). The L. donovani centrin-deleted (LdCen−/−)
parasites were used for immunization. The LdCen−/−
group received 107 LdCen−/− stationary phase promasti-
gotes subcutaneously (single-dose). The Leishmune® group
received three subcutaneous doses of vaccine (1 ml each)
with an interval of 21 days between each dose, as rec-
ommended by the manufacturer (Zoetis, Brazil). The
Control group received PBS alone. All animals were
challenged 2 months after the last dose of vaccine
(Leishmune® or LdCen−/−) or PBS. The blood collec-
tion to analyze the co-culture systems was performed
24 months after an intravenous challenge with 107 of
stationary phase promastigotes of L. infantum.
Ethical approval
The study was approved by the Ethical Committee for
Use of Experimental Animals of the Federal University
of Minas Gerais, Brazil (CETEA Protocol no.122/09 and
288/2012).
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Isolation of peripheral blood mononuclear cells
Blood samples (10 ml each) from the 17 dogs (control
group: n = 6; Leishmune® group: n = 5; LdCen−/− group:
n = 6) were collected in heparinized tubes intended for
obtaining peripheral blood mononuclear cells (PBMC),
as previously described [13]. Briefly, the whole blood
volume collected was placed in a mixture of Ficoll-
Hypaque (Sigma Chemical Co.; density: 1.119 g/ml) and
Ficoll-Hypaque (Sigma Chemical Co.; density: 1.077 g/
ml) at a 1:3 ratio (Ficoll/blood) in sterile polystyrene
conical bottom tubes (Falcon, Corning, USA). All sam-
ples were centrifuged at 700 × g for 80 min at 22 °C. The
PBMC ring was collected at the Ficoll-Hypaque interface
and transferred to another tube with 40 ml of Falcon
sterile 1× PBS containing 10 % FBS. This tube was cen-
trifuged twice at 400 × g for 10 min at 4 °C. After the
supernatant was discarded, the cells were resuspended
in 1 ml of cell culture medium RPMI 1640. Cells were
counted in a Neubauer hemocytometer chamber to de-
termine the numbers of monocytes or lymphocytes per
milliliter.
Microbicidal activity
The microbicidal activity was assessed using monocytes,
which were adjusted and plated at 5 × 105 monocytes/well
using 24-well plates (NUNC, Thermo Fisher Scientific Inc.,
USA), on circular coverslips (15 mm; Glasscyto, Brazil), as
previously described [13]. Briefly, cultures were established
using RPMI supplemented with 20 % fetal calf serum on
20 % macrophage colony-stimulating factor medium ob-
tained from supernatant of cultures of L929 immortalized
cells, and incubated at 37 °C/5 % CO2. Monocytes differen-
tiating into macrophages were evaluated at 5 days of cul-
ture, as previously described [12, 13]. The cells were
infected with 5 × 106 of L. infantum promastigotes in the
stationary phase, using a 10:1 ratio (ten parasites per
macrophage). Each well was gently washed 3 h after infec-
tion, and the cultures were maintained in co-culture with
CD4+ or CD8+ T-cells or CD4+:CD8+ T-cells simultan-
eously to assess microbicidal activity at 72 h after infection.
To calculate the rate of parasitic infection, the numbers of
amastigotes in 200 macrophages were counted. Afterwards,
the total number of amastigotes was divided by the total
number of infected macrophages to obtain the average
number of amastigotes per macrophage [12, 13].
Purification of CD4+ and CD8+ T-cells
After obtaining the PBMC by Ficoll-Hypaque gradient,
lymphocytes were submitted to further purification, as
previously described [12, 13]. CD4+ and CD8+ T-
lymphocytes were isolated using magnetic beads (Miltenyi
Biotec Inc., USA) by positive selection using anti-CD4 or
anti-CD8-FITC (fluorescein isothiocyanate) antibodies
(AbD Serotec, UK) and microbeads coated with anti-
FITC. Cell suspension was prepared at a concentration of
6 × 107 cells in a 1-ml tube in an isolation buffer contain-
ing PBS 1×, pH 7.2, 0.5 % BSA, and 2 mM EDTA. Mono-
clonal antibodies (CD4 or CD8-FITC) were added to 2 μl/
ml of total lymphocytes and incubated at room
temperature (RT) for 15 min. Next, magnetic microbeads
were added to 10 μl/ml lymphocytes and incubated for
15 min at RT. Cell suspension was loaded into a MACS
column (Miltenyi Biotec Inc.), which was placed in the
magnetic field of a MACS separator. The magnetically la-
beled CD4+ or CD8+ cells were retained in the column,
whereas the unlabeled cells ran through, resulting in this
cell fraction being depleted of CD4+ and CD8+ cells. After
removing the column from the magnetic field, the mag-
netically retained CD4+ and CD8+ cells were eluted as the
positively selected cell fraction by washing the magnetic
column with 15 ml of isolation buffer.
The purity of CD4+ and CD8+ T-cells was evaluated by
flow cytometry on a FACSCalibur instrument (Becton
Dickinson, USA) interfaced to an Apple G3 workstation.
Cell-Quest software (Becton Dickinson) was used for both
data acquisition and analysis. A total of 20,000 events were
acquired for each preparation. Flow cytometric analysis
was performed using canine whole blood leukocytes that
were selected on the basis of their characteristic forward
(FSC) and side (SSC) light-scatter distributions. Following
FSC and SSC gain adjustments, the lymphocytes were se-
lected by gating 1 on the FSC versus SSC graph. Fluores-
cence was evaluated from FITC spectra (anti-CD4 and
anti-CD8 antibodies) on FL1 in dot plot representations.
A marker was set as an internal control for nonspecific
binding to encompass > 98 % of the unlabeled cells, and
this marker was then used to analyze data for individual
animals. The results were expressed as the percentage of
positive cells within the selected gate for T-cell surface
markers presenting CD4+ or CD8+.
Co-culture system
After purification, the CD4+ and/or CD8+ T-cells were
incubated with macrophage (Mac) previously infected
with L. infantum promastigotes (10 parasites per macro-
phage) in the following proportions: to CD4+ T-cells:
Mac - 1 lymphocyte for each 2 macrophages (1:2) and to
CD8+ T-cells: ac - 1 lymphocyte for each 2 macrophages
(1:2). The culture of CD4+: CD8+ T-cells simultaneously
incubated under the same condition used ratios of 1:1:1
(CD4+: CD8+: Mac). Cells were grown in this co-culture
system for 72 h, as previously described [12, 13]. After-
wards, the well supernatants were collected and stored
at -80 °C for later cytokine measurements.
ELISA cytokine assay
Culture supernatants were collected at 72 h, and the
levels of IFN-γ, TNF-α, IL-12, IL-4, and IL-10 were
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titrated in culture supernatants using the ELISA method
(R&D Systems, USA). The plates were coated with anti-
IFN-γ, anti-TNF-α, anti-IL-12, anti-IL-4, and anti-IL-10
mAb in PBS, pH 7.4, and incubated at 4 °C overnight.
After blocking the wells using buffer containing PBS
plus 0.05 % (v/v) Tween 20 and 0.1 % (w/v) BSA, super-
natants were added to each well. Biotin-labeled mAb in
an incubation buffer was added to each well, and
streptavidin-HRP was used as an enzyme. The reaction
was developed using 3,3′,5,5′-tetramethylbenzidine sub-
strate and stopped by adding a 2.5 M H2SO4 solution.
The plates were washed after each step using PBS plus
0.05 % (v/v) Tween 20. Minimum sensitivity levels were
119 pg/ml for IFN-γ, 109 pg/ml for TNF-α, 102 pg/ml
for IL-12, 118,08 pg/ml for IL-4, and 89 pg/ml for IL-10.
All experiments were performed using 96-well plates
(COSTAR, Corning Inc., USA) and according to R&D
Systems instructions. Reading was performed using a
microplate automatic reader (EL800; Biotek, Winooski,
VT, USA) at a wavelength of 450 nm.
Statistical analysis
Statistical analysis was performed with GraphPad Prism
5.0 software (Prism Software, CA, USA). Data normality
was assessed using the Kolmogorov-Smirnov test. The
analyses of co-cultures and cytokines were performed
using repeated ANOVA measurements. Differences were
considered significant at P < 0.05.
Results
Immunization with LdCen−/− attenuated parasites
resulted in significant microbicidal activity of
macrophages co-cultured with CD4+ T-cells associated
with increased levels of Th1 cytokines
The performance of the co-culture system was evalu-
ated, including CD4+ T-cells, to analyze the contribution
of this cell subpopulation in the immunogenicity estab-
lishment. After 3 h of in vitro infection of macrophages
with L. infantum, macrophages from the LdCen−/−
group showed a lower (P = 0.049) frequency of infection
(Fig. 1a) as compared to the control group. The parasite
burden was reduced in macrophages in both LdCen−/−
(P = 0.0009) and Leishmune® (P = 0.005) groups as com-
pared to the control (Fig. 1b). Interestingly, 72 h after in
vitro infection, LdCen−/− group displayed an intense re-
duction (P = 0.012) in parasite burden as compared to
the Leishmune® group (Fig. 1c). LdCen−/− (P = 0.008)
and Leishmune® (P = 0.005) immunizations induced high
levels of cytokines IFN-γ (Fig. 1d), TNF-α (Fig. 1e) and
IL-12 (Fig. 1f ) and low levels of IL-4 (Fig. 1g) and IL-10
(Fig. 1h) in co-cultures as compared to the control
group. Remarkably, the LdCen−/− presented high levels
of IFN-γ when compared to the Leishmune® group
(Fig. 1d). Furthermore, both analyzed vaccines presented
a high IFN-γ/IL-10 ratio as compared to the control
group, with LdCen−/− displaying the highest (P = 0.006)
cytokine ratio (Fig. 1i).
LdCen−/− and Leishmune® immunized dogs induced an
intense microbicidal activity of macrophages co-cultured
with CD8+ T-cells and increased levels of pro-
inflammatory cytokines
Since the CD8+ T-lymphocytes act as effector cells to
control intracellular pathogens, this T-cell subset was
included in the co-culture system to analyze the induc-
tion of memory. LdCen−/− (P = 0.010) and Leishmune®
(P = 0.009) groups presented significant reduction in
the number of amastigotes in macrophages co-cultured
with CD8+ T cells as compared to the control group
(Fig. 2c). All analyzed pro-inflammatory cytokines
(IFN-γ, TNF-α, and IL-12; Fig. 2d-f ) presented high
levels in co-cultures of both LdCen−/− and Leishmune®
groups as compared to the control group. In contrast,
LdCen−/− (P = 0.018) and Leishmune® (P = 0.034)
groups displayed lower levels of IL-4 (Fig. 2g) and IL-
10 (Fig. 2h) as compared to the control group. Interest-
ingly, LdCen−/− (P = 0.006) and Leishmune® (P = 0.012)
groups showed increased IFN-γ/IL-10 ratio, in addition
to LdCen−/− immunization eliciting the highest (P =
0.008) cytokine ratio (Fig. 2i).
The co-culture system using macrophages plus CD4+:CD8
+ T-cells simultaneously revealed high anti-leishmanicidal
activity, increased levels of pro-inflammatory cytokines,
and a reduction of IL-4 and IL-10 in both LdCen−/− and
Leishmune® groups
The co-culture system using macrophages associated
with CD4+: CD8+ T-cells simultaneously was employed
to analyze the addictive effect of adaptive immune re-
sponse in the context of T-cells subsets. In this sense,
LdCen−/− (P = 0.001) and Leishmune® (P = 0.007) immu-
nizations induced a reduction in the parasite burden at
72 h post infection with L. infantum as compared with
the control group (Fig. 3c). The cytokine analysis re-
vealed high levels of IFN-γ (Fig. 3d), TNF-α (Fig. 3e) and
IL-12 (Fig. 3f ) in both LdCen−/− and Leishmune® groups
when compared to control group. Moreover, the Leish-
mune® immunization was able to induce high amounts
of TNF-α as compared to the LdCen−/− group (P =
0.042). Furthermore, both analyzed vaccines showed low
levels of IL-4 (Fig. 3d) and IL-10 (Fig. 3h). Similar to co-
cultures using purified CD4+ or CD8+ T-cells, the co-
culture system using CD4+:CD8+ T-cells simultaneously
was able to identify in LdCen−/− and Leishmune® groups
a high (P = 0.016) IFN-γ/IL-10 ratio, plus the LdCen−/−
group displayed the highest cytokine ratio (Fig. 2i).
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Fig. 1 Co-culture system using L. infantum infected macrophages (MØ) and CD4+ T-cells, 24 months after experimental challenge with L. infantum. Control
group (n= 6 dogs) and Leishmune® (n= 5 dogs) received three doses of PBS or vaccine, respectively, at 21 day intervals; LdCen−/− group (n= 6 dogs)
received 107 LdCen−/− stationary phase promastigotes in single-dose. a Infection rate (%) of macrophages after 3 h of in vitro infection with L. infantum
(5 × 106 promastigotes; ratio ten parasites: 1 MØ). b Number of amastigote forms by macrophages after 3 h of in vitro infection with L. infantum. c Number
of amastigote forms by macrophages after 72 h of in vitro infection with L. infantum. The cytokine profile (pg/mL) was analyzed in supernatant from L.
infantum infected macrophages (MØ) co-cultured with CD4+ T-cells for IFN-γ (d), TNF-α (e), IL-12 (f), IL-4 (g), IL-10 (h) and IFN-γ/IL-10 ratio (i). The x-axis
represents the control group (C), Leishmune® and LdCen−/− vaccines. The connecting lines between the bars indicate significant differences (P< 0.05)
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Fig. 2 Co-culture system using L. infantum infected macrophages (MØ) and CD8+ T-cells, 24 months after experimental challenge with L.
infantum. Control group (n = 6 dogs) and Leishmune® (n = 5 dogs) received three doses of PBS or vaccine, respectively, at 21 day intervals;
LdCen−/− group (n = 6 dogs) received 107 LdCen−/− stationary phase promastigotes in single-dose. a Infection rate (%) of macrophages
after 3 h of in vitro infection with L. infantum (5 × 106 promastigotes; ratio ten parasites: 1 MØ). b Number of amastigote forms by macrophages
after 3 h of in vitro infection with L. infantum. c Number of amastigote forms by macrophages after 72 h of in vitro infection with L. infantum. The cytokine
profile (pg/mL) was analyzed in supernatant from L. infantum infected macrophages (MØ) co-cultured with CD8+ T-cells for IFN-γ (d), TNF-α (e), IL-12 (f), IL-
4 (g), IL-10 (h) and IFN-γ/IL-10 ratio (i). The x-axis represents the control group (C), Leishmune® and LdCen−/− vaccines. The connecting lines between the
bars indicate significant differences (P< 0.05)
Viana et al. Parasites & Vectors  (2016) 9:250 Page 6 of 10
Fig. 3 Co-culture system using L. infantum infected macrophages (MØ) and CD4+: CD8+ T-cells, 24 months after experimental challenge with L. infantum.
Control group (n= 6 dogs) and Leishmune® (n= 5 dogs) received three doses of PBS or vaccine, respectively, at 21 day intervals; LdCen−/− group (n= 6
dogs) received 107 LdCen−/− stationary phase promastigotes in single-dose. a Infection rate (%) of macrophages after 3 h of in vitro infection with
L. infantum (5 × 106 promastigotes; ratio ten parasites: 1 MØ). b Number of amastigote forms by macrophages after 3 h of in vitro infection
with L. infantum. c Number of amastigote forms by macrophages after 72 h of in vitro infection with L. infantum. The cytokine profile (pg/
mL) was analyzed in supernatant from L. infantum infected macrophages (MØ) co-cultured with CD4+:CD8+ T-cells for IFN-γ (d), TNF-α (e),
IL-12 (f), IL-4 (g), IL-10 (h) and IFN-γ/IL-10 ratio (i). The x-axis represents the control group (C), Leishmune® and LdCen−/− vaccines. The
connecting lines between the bars indicate significant differences (P < 0.05)
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Discussion
This study applied previously standardized protocols
[12, 13] of co-culture systems using L. infantum-in-
fected macrophages and purified CD4+ or CD8+ T-
cell subsets from immunized dogs, 24 months after
experimental challenge with a virulent strain of L.
infantum. This method was previously developed to
analyze vaccine candidates against canine visceral
leishmaniasis [12, 13]. LdCen−/− and Leishmune® vac-
cines were used as they have demonstrated a strong
immunogenicity [10, 11, 14–18].
In this sense, it has been described that immunization
with LdCen−/− in dogs elicited high levels of serum immu-
noglobulins, a lymphoproliferative response, and T-cell
activation, which increased production of Th1 cytokines
and decreased secretion of Th2 cytokines [14]. Further-
more, it was also shown that LdCen−/− and Leishmune®
immunizations resulted in significant protection, as re-
vealed by the low parasite burden in the bone marrow at
18 months and even 24 months post challenge [11, 14].
The parasite burden level observed in the LdCen−/− and
Leishmune® immunized group is comparable to that typic-
ally observed in asymptomatic dogs, which are PCR posi-
tive [19], suggesting a robust degree of protection. These
data support the application of LdCen−/− and Leishmune®
immunizations in the current evaluation as reference
vaccines to validate the proposed co-culture system.
Most studies involving co-culture of macrophages and
lymphocytes are empirically developed, using total lym-
phocytes, and do not reflect the cytokine levels of the T-
cells. The method described in this study applied a new,
more accurate approach that yields useful laboratory
parameters to evaluate the ability of canine immune cells
to control in vitro L. infantum infection as a biomarker
to identify the immunogenicity mechanism.
Traditional immunogenicity studies in vaccines against
CVL, such as Leishvacin or Leishmune®, have described
the biomarkers regarding increased percentage of T lym-
phocytes producing IFN-γ, especially CD4+ T-cells [15, 16].
Moreover, LiESAp-MDP vaccine elicited protection that
was correlated with the early establishment of a long-
lasting, predominantly Th1-type cellular immune response
relationship to enhanced in vitro leishmanicidal activity of
macrophages in response to higher IFN-γ production by T-
cells [20]. Recently, a study evaluating the LiESP/QA-21
(CaniLeish®) vaccine demonstrated strong cell-mediated
immune responses against the parasite despite a virulent
challenge associated with a lower probability of developing
active infections [21]. Furthermore, tests for microbicidal
activity of macrophages cultured with autologous total lym-
phocytes showed that the vaccinated group inhibited twice
the parasite replication in comparison with the control
group [21]. However, the ideal method for identifying the
protective mechanisms induced by vaccine against canine
visceral leishmaniasis would analyze the effector immune
response. In this sense, the leishmanicidal effect could be
evaluated as an effector mechanism induced by T-cells sub-
sets co-cultured with L. infantum infected macrophages.
Our data demonstrated that the three co-culture
systems (L. infantum infected macrophages with puri-
fied CD4+ or CD8+ T-cells or CD4+:CD8+ T-cells
simultaneously) from LdCen−/− and Leishmune® were
able to identify a significant reduction in the parasitic
burden. Noteworthy is the fact that the co-culture
system containing a purified CD4+ T-cell subset was
able to recognize a differential capacity of LdCen−/−
vaccine to induce a strong in vitro leishmanicidal con-
trol when compared to Leishmune® immunization. In
fact, the strong leishmanicidal ability could be associ-
ated with differential IFN-γ production in addition to
a higher IFN-γ/IL-10 ratio, as presented by the co-
culture system containing the purified CD4+ T-cell
subset. In previous studies regarding asymptomatic L.
infantum-infected dogs, co-cultures with CD8+ T-cells
and infected-macrophages were able to produce high
levels of IFN-γ, whereas cells from symptomatic dogs
did not [22].
Type 1 cytokine analysis has been considered a pre-
requisite for immunogenicity analyses before and after
experimental challenge with L. infantum in clinical anti-
CVL vaccine trials [6, 12]. In fact, the co-culture system
proposed herein was able to identify the type 1 cytokine
pattern, in agreement with an earlier studies for both
LdCen−/− and Leishmune® immunizations [11, 14]. More-
over, Leishmune® immunization elicited high TNF-α pro-
duction in a co-cultured system with CD4+:CD8+ T-cells
simultaneously, but without effect in producing differential
parasitism control when compared to LdCen−/−. Interest-
ingly, IFN-γ, but not TNF-α levels, was associated with
immunogenicity and protection in dogs immunized with
LBSap vaccine [23]. Furthermore, it was reported that dogs
immunized with purified excreted-secreted antigens of
Leishmania infantum presented high levels of IFN-γ in co-
culture with L. infantum infected macrophages and total
lymphocytes, inducing a microbicidal effect [24, 25].
Considering the previous studies describing strong
immunogenicity elicited by LdCen−/− and Leishmune®
immunizations, this study applied a new approach
based on a co-culture system using L. infantum in-
fected macrophages and purified T-cell subsets after
vaccination and experimental L. infantum challenge.
Data from this study indicated that the co-culture
system was able to identify the immunogenicity mech-
anism induced by LdCen−/− and Leishmune® vaccin-
ation in dogs, in addition to associating an effector
mechanism (in vitro leishmanicidal control by L.
infantum infected macrophages) regarding an induc-
tion of T-cell memory.
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Conclusions
The low levels of type 2 cytokines (IL-4 and IL-4), high
amounts of type 1 cytokines (IFN-γ, TNF-α and IL-12),
and increased IFN-γ/IL-10 ratio were associated with a
leishmanicidal effect of L. infantum infected macro-
phages, using co-culture systems with CD4+ or CD8+ or
CD4+: CD8+ T-cells simultaneously. This strategy was
able to validate the distinct conditions of the analyzed
co-culture systems. Thus, taken together, the data point
to the in vitro co-culture systems providing a rapid assay
to test and monitor the immunogenicity and efficacy of
Leishmania vaccines in dogs.
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